Locations:

Patients Know Less Than They Think About Their CIEDs, Survey Finds

Results also show eagerness to learn more

19-HRT-6548-CIED-650×450

When asked to answer seven basic questions about their cardiac implantable electronic device (CIED), a majority of patients completing a Cleveland Clinic questionnaire came up short on at least two questions. At baseline, most patients felt they had a good understanding of their CIED (i.e., permanent pacemaker, defibrillator or biventricular device) but expressed a desire to be able to access additional data provided by the device. .

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The prospective survey study was published in Pacing and Clinical Electrophysiology: PACE (2019 Nov 28 [Epub ahead of print]).

“Although the majority of patients with a CIED believe they are knowledgeable about their device, most actually struggle with basic information that electrophysiologists would want their patients to know,” says Cleveland Clinic electrophysiologist Khaldoun Tarakji, MD, MPH, senior author of the study.

Growth in devices and data access

CIEDs have become more common at the same time that digital technology has allowed patients to access ever-increasing amounts of data from them. Devices can store information and transmit it via cellular networks, enabling patients to bypass visits with their cardiologist for device evaluations and be monitored from home instead. More recent advances allow CIEDs to transmit data directly to patients’ tablets and smartphones, which can then be forwarded to a physician.

“The prospect of patients having access to ever more detailed health data begs the question of whether they know what the information means and whether they even want it,” notes study co-author Oussama Wazni, MD, Section Head of Cardiac Electrophysiology and Pacing at Cleveland Clinic.

Other studies have assessed patients’ understanding of and attitudes toward their CIEDs, and have generally found that patients feel they are knowledgeable and want data from their device. However, no previous published study has directly tested patients’ understanding of their devices.

Study design and findings

The study screened 400 patients with either a permanent pacemaker, an implantable cardioverter defibrillator (ICD) or a biventricular device who presented to Cleveland Clinic’s outpatient device clinic for routine device interrogation between July and December 2018. All were offered a two-page questionnaire to complete independently in 15 minutes.

Advertisement

The questionnaire covered demographics and patients’ perceived knowledge of their device and contained multiple-choice questions to assess basic knowledge of their device. Investigators compared survey responses to individual device interrogation reports.

A total of 344 patients completed the questionnaire and were included in the analysis. Key findings are highlighted below.

Demographics. Mean patient age was 62.9 + 12.8 years; 64% of the sample were men. All but 6% had graduated from high school, with 53% graduating from college or achieving a master’s or doctoral degree.

Perceived knowledge. Most agreed (47.3%) or strongly agreed (15.9%) with the statement, “I feel that I am knowledgeable about my device,” while only 7.2% disagreed and 3.8% strongly disagreed.

Actual knowledge. The multiple-choice knowledge test covered seven areas and had the following results:

  • Device manufacturer: 91% correct
  • Number of shocks received since prior evaluation (0, 1, >1): 82% correct
  • Reason for implant (heart failure, sick sinus node/slow heart rate, sudden cardiac arrest): 77% correct
  • Type of device (pacemaker, ICD, biventricular device): 74% correct
  • Function(s) of device (pace/stimulate, shock, synchronization): 70% correct
  • Number of active leads (0, 1, 2, 3): 64% correct
  • Battery life (<1 year, 1-2 years, 2-5 years, 5-15 years): 59% correct

Overall, 85.5% of patients answered one or more questions incorrectly, 51.2% answered at least two incorrectly, 23.0% answered at least three incorrectly and 9.3% answered at least four incorrectly.

Advertisement

Desire to know more. Patients were also asked which among 11 content areas they agreed or strongly agreed it would be useful to know about. All 11 were deemed useful by a majority of patients, and some of the highest levels of interest were in battery life, activity level, atrial arrhythmia burden, current heart rhythm and heart rate trend.

Helping patients cope with increasing information

“Arrhythmia care is undergoing a transformation as patients gain more access to their CIED data,” observes Dr. Wazni. “But whether more information will lead to better outcomes is still uncertain.” He notes that it could promote better self-care, as has been shown in some studies when patients are better informed of their cardiac risk factors. On the other hand, more access to electrophysiology data could lead to increased confusion, anxiety and unnecessary demands on healthcare resources.

“New technologies are increasingly making patients active drivers in their healthcare management,” adds Dr. Tarakji. “It is incumbent upon physicians and device manufacturers to not only provide patients with health-related data but help them understand it.”

Advertisement

Related Articles

axial image of the human chest showing the heart and other organs

How Imaging Can Guide Smarter Aortic Valve and Root Decisions

New review proposes a multimodality framework for matching patients to procedures

color cardiac echo next to model of a bulging aorta

Distinctive CME on Valve Imaging and Connective Tissue Disorders on Tap for March 2027

In-depth live symposia in Florida and Cleveland feature interdisciplinary experts from around the nation

yellow and red illustration of blood cells moving through a blood vessel

First-in-Human Data Show One siRNA Can Lower Both LDL-C and Triglycerides

Early results for ARO-DIMER-PA point to a more streamlined way to treat mixed hyperlipidemia

blood vessel on top of a DNA double helix

CRISPR-Cas9 Gene Editing Therapy Safely Slashes Severely Elevated Triglycerides in Early Trial

Findings support further studies of potential one-time treatment strategy

two side-by-side medical illustrations with red trend line overlays

Lipoprotein(a) Reduction With Pelacarsen Has No Impact on Cardiac Events, Lp(a)HORIZON Finds

But unexpected results are ‘not the end of the story’ for Lp(a) lowering, investigators say

stylized heart and lungs with text overlay

Outcome Updates in Adult Cardiac Surgery, Ischemic Heart Disease and Vascular Disease

A scannable snapshot of recent volumes and results

illustration of aortic arch after stent graft repair

Evolving Strategies in Aortic Arch Repair (Podcast)

Earlier detection is reshaping timing and safety of these increasingly common surgeries

illustrated human gut with microbes and an overlay of a rhythm tracing

TMAO Shown to Be a Modifiable Risk Factor for Atrial Fibrillation

Bench-to-bedside study identifies mechanism and potential therapeutic target

Ad